The authors first evaluated patients with sarcopenia, osteoporosis, or osteosarcopenia, and found significantly decreased levels of IL-33 in skeletal muscle, bone matrix, proximal bone marrow, and serum of osteosarcopenia patients. Here, IL33 is linked to sarcopenia.